OIG To Study How CMS Looks At National Security When Certifying Labs

By Michelle M. Stein
September 3, 2019 at 7:08 PM
The HHS Office of Inspector General is planning a review of whether CMS considers national security risks when certifying labs that conduct genomic testing. The review is in response to concerns from Senate Finance Chair Chuck Grassley (R-IA) and Sen. Marco Rubio (R-FL) that CMS may be paying for genetic testing conducted by U.S. entities partnered with companies tied to the Chinese government. “In response to your request, we are planning a review of CMS controls to determine whether CMS...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.